Objectives-It has been shown previously that hyaluronic acid (HA) has an analgesic action on bradykinin induced pain in the knee joints of rats. This study further clarifies the effects of the molecular weight of HA and its mechanism of action in the same model using HA Conclusions-HA with a molecular weight of greater than 40 kilodaltons produced an analgesic effect, and HA of 860 and 2300 kilodaltons produced high and longlasting analgesia. These effects of HA appear to be caused by the interaction between HA and HA receptors.
Conclusions-HA with a molecular weight of greater than 40 kilodaltons produced an analgesic effect, and HA of 860 and 2300 kilodaltons produced high and longlasting analgesia. These effects of HA appear to be caused by the interaction between HA and HA receptors. The main clinical symptom of osteoarthritis is joint pain, which makes daily life unpleasant. The pain may also promote progress of the disease process,'"3 and result in decreased mobility of the joint due to lack of use. Consequently, reducing pain is important for the maintenance of joint activity and quality of life.
Hyaluronic acid (HA) is the main component of synovial fluid. High molecular weight HA with a random coil configuration has viscoelasticity and occupies a large amount of hydrodynamic space in solution. 4 Its functions in the joint are considered to be as a lubricant,56 a protector of cartilage,7-9 and an effector of the metabolism of synovial tissue.'0 Intra-articular HA treatment of the knee of patients with osteoarthritis reduces painful symptoms and improves general activities of daily living and joint mobility."-"' The mechanism of joint pain is not clear, so the role of HA in pain suppression requires further study. In our previous study using the bradykinin induced joint pain model in rats, we showed that HA acting in a joint can induce analgesia. 14 In this study we investigated the effects of the molecular weight of HA on analgesia and further attempted to clarify its mode of action using HA of molecular weight 800 to 2-3 X 106 daltons in the same model.
Materials and methods

MATERIALS
HA preparations were extracted and highly purified from rooster combs; their average molecular weights were 6-8 (HA [6] [7] [8] Each HA was injected into a joint simultaneously with bradykinin (n = 6-31). *p < 0-05; **p < 0 01. Molecular weight ofHA-6-8, HA-40, HA-310, HA-860, and HA-2300 are [6] [7] [8] 40 4S HA, 8S HA, and HA 68. The pain reaction was induced by the injection of bradykinin alone and by the simultaneous injection of bradykinin and HA 860 of 10 mg/ml 30 minutes after administration of 4S HA, 8S HA, and HA 6&8. HA 860 inhibited the pain in knees with preinjected saline, 4S HA of 10 mg/ml, and 8S HA of 2-5 mg/ml, but did not inhibit it in knees injected with 10 mg/ml Bradykinin antagonist at 2-5 and 1O,ug/ml inhibited pain, depending on the dose, when injected simultaneously with 5 ,ug/ml bradykinin ( fig 7) . As the bradykinin antagonist has a short life in vivo, bradykinin was injected five minutes after administration of the bradykinin antagonist. This short interval between injections enhanced the pain. Thus in this test a bradykinin concentration of 2-5 pLg/ml was chosen to obtain an analgesic score of 3 in the control group for easy rating. HA receptors. A pain reaction was induced by injecting [2] [3] [4] [5] ,ug/ml bradykinin five minutes after administration of bradykinin antagonist (10 ,ug/ml), HA 6 8 (10 mg/ml), and a mixture of the two. Bradykinin antagonist and the mixture with HA 6-8 inhibited the pain equally, but HA 6* 8 did not. This indicates that HA had no effect on the interaction between bradykinin and bradykinin receptors (fig 8) . We had previously proposed another possible explanation for the analgesic action. HA has an expanded random coil configuration which causes entanglement between neighbouring molecules. We had thought that HA in the synovial fluid may trap bradykinin in its molecule by the ion bonds formed between the carboxyl base in HA with the negative charge and bradykinin with the cation charge, followed by maintaining an entangled coil configuration. This is not feasible, however, because analgesia by HA 860 no longer occurred after HA oligosaccharide pretreatment, as shown in fig 5, and when the bradykinin solution was dialysed with the filter membrane, the dialysis rate of bradykinin was not changed by adding HA in solution (data not shown).
The results of this study indicate that (a) HA with a molecular weight greater than 40 kilodaltons produces analgesic effect, (b) high and longlasting analgesia is induced by HA with molecular weights of 860 and 2300 kilodaltons equally, and (c) that analgesia was inhibited by oligosaccharides of HA. Moreover, HA did not directly bind to bradykinin receptors, indicating that analgesia of HA appears to be brought on by the interaction of HA and HA receptors on or surrounding the free nerve endings that detect pain in the joint tissue. 
